{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-109401","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.426348+00:00","generated_at":"2026-05-30T13:15:04.046619+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ReShape Lifesciences issues $833,333 senior secured convertible note to institutional investor","bullets":["Issued $833,333.34 convertible note with 10% annual interest, due Jan 16, 2025 or upon close of Vyome merger.","Investor received 7,983 shares of common stock as commitment shares in connection with the note.","Note is secured by substantially all assets of ReShape Lifesciences, including intellectual property and patents.","Directors and officers entered lock-up agreements barring disposal of company shares while note is outstanding.","Investor agreed to a leak-out restriction limiting daily sales to 10% of composite trading volume of RSLS."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-109401","json":"https://secwatch.observer/filing/0001104659-24-109401.json","markdown":"https://secwatch.observer/filing/0001104659-24-109401.md","text":"https://secwatch.observer/filing/0001104659-24-109401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924109401/0001104659-24-109401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465924109401/tm2426316d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:15:04.046619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}